Baxter International (MEX:BAX) Short-Term Debt: MXN15,184 Mil (As of Mar. 2026)


MEX:BAX Baxter International Inc MEX:BAX
44 GF Score
Price MXN368.00
GF Value MXN623.40
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Baxter International Short-Term Debt?

Baxter International MEX:BAX 44 Short-Term Debt is MXN15,184 Mil as of Mar. 2026. GuruFocus rates MEX:BAX with a GF Score™ of 44/100 and a GF Value™ of MXN623.40 (Possible Value Trap). The stock has 7 warning signs investors should review.

Baxter International's Short-Term Debt for the quarter that ended in Mar. 2026 was MXN15,184 Mil.

Baxter International's quarterly Short-Term Debt declined from Sep. 2025 (MXN13,850 Mil) to Dec. 2025 (MXN54 Mil) but then increased from Dec. 2025 (MXN54 Mil) to Mar. 2026 (MXN15,184 Mil).

Baxter International's annual Short-Term Debt increased from Dec. 2023 (MXN45,270 Mil) to Dec. 2024 (MXN57,395 Mil) but then declined from Dec. 2024 (MXN57,395 Mil) to Dec. 2025 (MXN54 Mil).

Baxter International Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Baxter International Short-Term Debt Related Terms

Baxter International Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Baxter International's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Baxter International Short-Term Debt Chart

Baxter International Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10,482.65 27,372.38 45,270.32 57,394.89 54.02

Baxter International Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13,543.33 150.63 13,849.87 54.02 15,183.53
MEX:BAX
44GF Score
Baxter International Inc MEX:BAX
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of MXN15,184 Mil mean?
Baxter International (MEX:BAX) has a Short-Term Debt of MXN15,184 Mil as of Mar. 2026.
Is Baxter International's Short-Term Debt too high?
Baxter International's current Short-Term Debt is MXN15,184 Mil. Overall, Baxter International has a GF Score™ of 44/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Baxter International's Short-Term Debt compare to ALGN and SOLV?
Baxter International's Short-Term Debt of MXN15,184 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Medical Devices & Instruments company?
A good Short-Term Debt depends on the Medical Devices & Instruments industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Baxter International's current Short-Term Debt is MXN15,184 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Baxter International stock overvalued right now?
Based on GuruFocus' analysis, Baxter International (MEX:BAX) is currently considered Possible Value Trap. The stock's GF Value™ is MXN623.40, compared to a current price of MXN368.00 — trading 41% below its estimated fair value. The current Short-Term Debt is MXN15,184 Mil. Baxter International's overall GF Score™ is 44/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Baxter International (MEX:BAX), the current Short-Term Debt is MXN15,184 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Baxter International (MEX:BAX) Overvalued in 2026?

Based on GuruFocus' analysis, Baxter International stock appears to be undervalued. The current stock price of MXN368.00 is trading 41% below its estimated GF Value™ of MXN623.40. GuruFocus considers Baxter International to be Possible Value Trap.

Key valuation signals for MEX:BAX:

  • Short-Term Debt: MXN15,184 Mil
  • GF Value™: MXN623.40 vs. price of MXN368.00 (41% below fair value)
  • GF Score™: 44/100 with 7 warning signs

No single metric tells the full story. See the MEX:BAX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Baxter International Business Description

Address One Baxter Parkway, Deerfield, IL, USA, 60015
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
44GF Score

Get the complete analysis for MEX:BAX

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN368.00
Price
MXN623.40
GF Value